A Anagnostou

2.0k total citations · 1 hit paper
34 papers, 1.6k citations indexed

About

A Anagnostou is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, A Anagnostou has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 10 papers in Physiology and 8 papers in Genetics. Recurrent topics in A Anagnostou's work include Erythropoietin and Anemia Treatment (16 papers), Erythrocyte Function and Pathophysiology (10 papers) and Hemoglobinopathies and Related Disorders (5 papers). A Anagnostou is often cited by papers focused on Erythropoietin and Anemia Treatment (16 papers), Erythrocyte Function and Pathophysiology (10 papers) and Hemoglobinopathies and Related Disorders (5 papers). A Anagnostou collaborates with scholars based in United States and France. A Anagnostou's co-authors include M. Steiner, Eleanor S. Lee, Noubar Kessimian, Ralph D. Levinson, Manfred Steiner, George Sigounas, Zhihong Liu, Kyung Chin, Constance Tom Noguchi and W Fried and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer.

In The Last Decade

A Anagnostou

34 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.

1990 481 citations A Anagnostou, Eleanor S. Lee et al. Proceedings of the National Academy of Sciences profile →

Peers

A Anagnostou

HEMAT

MB

GENET

PHYSI

ONCOL

Elisabeth Koller Austria

RI Handin United States

J P Le Couedic France

Gertie Gorter Netherlands

Órla P. Barry Ireland

Roger van Kruchten Netherlands

Christilla Bachelot‐Loza France

RL Kinlough-Rathbone Canada

Jianlin Qiao China

H. E. Abboud United States

Elisabeth Koller Austria

A Anagnostou

720 ×0.7

HEMAT

481 ×1.0

MB

185 ×0.6

GENET

83 ×0.3

PHYSI

257 ×1.1

ONCOL

Citations per year, relative to A Anagnostou A Anagnostou (= 1×) peers Elisabeth Koller

Countries citing papers authored by A Anagnostou

Since Specialization

Citations

This map shows the geographic impact of A Anagnostou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Anagnostou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Anagnostou more than expected).

Fields of papers citing papers by A Anagnostou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Anagnostou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Anagnostou. The network helps show where A Anagnostou may publish in the future.

Co-authorship network of co-authors of A Anagnostou

This figure shows the co-authorship network connecting the top 25 collaborators of A Anagnostou. A scholar is included among the top collaborators of A Anagnostou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Anagnostou. A Anagnostou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Sigounas, George, Jerry L. Hooker, A Anagnostou, & Manfred Steiner. (1997). S‐allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. Nutrition and Cancer. 27(2). 186–191. 91 indexed citations

2.

Li, Wei, et al.. (1997). Dl-alpha-tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukemia cells. Journal of Cellular Physiology. 172(3). 351–360. 22 indexed citations

3.

Sigounas, George, A Anagnostou, & Manfred Steiner. (1997). dl‐α‐tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutrition and Cancer. 28(1). 30–35. 109 indexed citations

4.

Sigounas, George, Jerry L. Hooker, Wei Li, A Anagnostou, & Manfred Steiner. (1997). S‐Allylmercaptocysteine, a stable thioallyl compound, induces apoptosis in erythroleukemia cell lines. Nutrition and Cancer. 28(2). 153–159. 52 indexed citations

5.

Steiner, Manfred, et al.. (1997). Dl‐alpha‐tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro‐ and megakaryoblastic leukemia cells. Journal of Cellular Physiology. 172(3). 351–360. 1 indexed citations

6.

Sigounas, George, Manfred Steiner, & A Anagnostou. (1997). Synergism of Hemopoietic Growth Factors on Endothelial Cell Proliferation. Angiology. 48(2). 141–147. 6 indexed citations

7.

Anagnostou, A, Nicholas Dainiak, & A Najman. (1991). Positive News on the Negative Growth Factors. Annals of the New York Academy of Sciences. 628(1). 1–8. 2 indexed citations

8.

Anagnostou, A, Eleanor S. Lee, Noubar Kessimian, Ralph D. Levinson, & M. Steiner. (1990). Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.. Proceedings of the National Academy of Sciences. 87(15). 5978–5982. 481 indexed citations breakdown →

9.

Anagnostou, A, et al.. (1988). Recurrence of Hodgkin's disease 29 years later. Cancer. 61(1). 186–188. 6 indexed citations

10.

Miller, Marilyn E., et al.. (1987). Effect of fish oil concentrates on hemorheological and hemostatic aspects of diabetes mellitus: A preliminary study. Thrombosis Research. 47(2). 201–214. 28 indexed citations

11.

Anagnostou, A & Neil A. Kurtzman. (1985). The anemia of chronic renal failure.. PubMed. 5(2). 115–27. 18 indexed citations

12.

Anagnostou, A. (1985). Erythropoietin: a hematopoietic hormone produced by the kidney.. PubMed. 5(2). 104–14. 4 indexed citations

13.

Hall, R R, et al.. (1984). Pneumatosis intestinalis associated with graft-versus-host disease of the intestinal tract.. PubMed. 16(6). 1666–8. 15 indexed citations

14.

Anagnostou, A, Axel R. Zander, Lijda Vellekoop, et al.. (1984). HIGH-DOSE METHYLPREDNISOLONE TREATMENT FOR ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION IN ADULTS. Transplantation. 37(3). 246–248. 46 indexed citations

15.

Pololi, Linda H., Stanley G. Schade, & A Anagnostou. (1981). The effect of estrogens on erythroid stem cells in polycythemic mice. Molecular and Cellular Endocrinology. 24(1). 73–84. 3 indexed citations

16.

Pololi, Linda H., Stanley G. Schade, & A Anagnostou. (1981). The effect of protein deprivation on erythroid stem cell growth.. PubMed. 51(1). 59–63. 1 indexed citations

17.

Fried, W, J Barone, Stanley G. Schade, & A Anagnostou. (1979). Effect of carbon tetrachloride on extrarenal erythropoietin production in rats.. PubMed. 93(5). 700–5. 16 indexed citations

18.

Fried, W, et al.. (1978). Effect of protein deprivation on hematopoietic stem cells and on peripheral blood counts.. PubMed. 92(2). 303–10. 24 indexed citations

19.

Anagnostou, A, et al.. (1977). Effect of protein deprivation on erythropoiesis. Blood. 50(6). 1093–1097. 42 indexed citations

20.

Anagnostou, A, et al.. (1977). Effect of Erythropoietin Therapy on the Red Cell Volume of Uraemic and Non‐uraemic Rats. British Journal of Haematology. 37(1). 85–91. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact